Product Program year 2024 Source: CMS Open Payments

Quadra Assura

Device Cardiac Rhythm Management

PDI 05414734508285

Open in the dashboard

General payments

$201,854

2,987 payments

Research payments

$3,495

4 payments

Through program year 2024, $201,854 in general payments and $3,495 in research payments were reported against Quadra Assura (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2024 General $1,593 76
2023 General $18,771 344
2023 Research $200 1
2022 General $181,309 2,566
2022 Research $3,295 3
2021 General $181 1

Breakdown

Who paid General payments · program years 2021–2024
  1. Abbott Laboratories $201,854 2,987 payments
Top recipients General payments · program year 2024
  1. Marvin Lu Cardiovascular Disease · Daytona Beach, FL $152 10% · 1 payment
  2. Mayank Yadav Orange City, FL $152 10% · 1 payment
  3. Jackson Liang Clinical Cardiac Electrophysiology · Ann Arbor, MI $126 8% · 1 payment
  4. Alexander Turin Cardiovascular Disease · Ann Arbor, MI $126 8% · 1 payment
  5. David Sterns Clinical Cardiac Electrophysiology · Omaha, NE $103 6% · 8 payments

The top 5 of 62 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $524 37% · 21 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $437 31% · 19 practitioners
  3. Hospitalist $110 8% · 2 practitioners
  4. Internal Medicine $94 7% · 4 practitioners
  5. Interventional Cardiology Internal Medicine $69 5% · 7 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Michigan $252 16% · 2 recipients
  2. Texas $228 14% · 13 recipients
  3. New York $173 11% · 3 recipients
  4. Florida $167 10% · 5 recipients
  5. Pennsylvania $148 9% · 8 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

2,987 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record